We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
-7.79%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$1.41B
AUM Growth
-$143M
Cap. Flow
+$78.9M
Cap. Flow %
5.61%
Top 10 Hldgs %
48.2%
Holding
246
New
54
Increased
32
Reduced
53
Closed
52

Top Buys

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$38M
2
FOLD
Amicus Therapeutics
FOLD
+$22M
3
ACRS icon
Aclaris Therapeutics
ACRS
+$21.2M
4
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$18.7M
5
ANIP icon
ANI Pharmaceuticals
ANIP
+$15.6M

Top Sells

Rank Stock Value
1
SRPT icon
Sarepta Therapeutics
SRPT
+$25.1M
2
DXCM icon
DexCom
DXCM
+$15.7M
3
AERI
Aerie Pharmaceuticals
AERI
+$13.5M
4
ASRT
Assertio
ASRT
+$13.4M
5
CRBP icon
Corbus Pharmaceuticals
CRBP
+$11.1M

Sector Composition

Rank Sector Weight
1 Healthcare 97.84%
2 Miscellaneous 1.6%
3 Consumer Staples 0.43%
4 Consumer Discretionary 0.07%
5 Industrials 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RNAC icon
76
Cartesian Therapeutics
RNAC
$239M
$2.43M 0.17%
4,729
-6,876
-59% -$4.02M
APVO icon
77
Aptevo Therapeutics
APVO
$3.1M
– –
0
– –
CASC
78
DELISTED
Cascadian Therapeutics, Inc.
CASC
$2.35M 0.17%
546,498
-22,522
-4% -$146K
ABT icon
79
Abbott
ABT
$177B
$1.92M 0.14%
50,000
+3,981
+9% +$158K
AERI
80
DELISTED
Aerie Pharmaceuticals
AERI
$1.89M 0.13%
50,000
-356,771
-88% -$13.5M
ATRC icon
81
AtriCure
ATRC
$2.86B
$1.85M 0.13%
94,400
+86,451
+1,088% +$1.57M
EIGR
82
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1.84M 0.13%
5,256
+925
+21% +$339K
PFE icon
83
Pfizer
PFE
$157B
$1.79M 0.13%
+57,970
New +$1.77M
TXMD icon
84
TherapeuticsMD
TXMD
$25M
$1.73M 0.12%
+6,000
New +$1.86M
AVEO
85
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$1.68M 0.12%
310,881
– –
GNMX
86
DELISTED
Aevi Genomic Medicine Inc
GNMX
$1.52M 0.11%
293,460
– –
AFMD
87
DELISTED
Affimed
AFMD
$1.32M 0.09%
73,430
– –
ARWR icon
88
Arrowhead Research
ARWR
$9.98B
$1.31M 0.09%
847,458
– –
NDRM
89
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$1.28M 0.09%
57,825
-206,289
-78% -$3.86M
ADYX
90
DELISTED
Adynxx Inc
ADYX
$1.13M 0.08%
32,033
– –
GRDX
91
GridAI Technologies Corp
GRDX
$21.5M
$1.08M 0.08%
+2
New +$1.16M
MDCO
92
PUT
DELISTED
Medicines Co
MDCO
$1.07M 0.08%
+200,000
New +$7.09M
VXX
93
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$1.05M 0.07%
+10,250
New +$1.23M
BCLI
94
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$1.02M 0.07%
+26,667
New +$924K
CSBR icon
95
Champions Oncology
CSBR
$66.4M
$942K 0.07%
372,597
– –
QHC
96
DELISTED
Quorum Health Corporation
QHC
$731K 0.05%
+100,604
New +$606K
AH
97
DELISTED
Accretive Health
AH
$709K 0.05%
315,000
+190,000
+152% +$428K
WCG
98
DELISTED
Wellcare Health Plans, Inc.
WCG
$693K 0.05%
5,056
– –
EXEL icon
99
Exelixis
EXEL
$14.1B
$691K 0.05%
+46,361
New +$669K
UTHR icon
100
United Therapeutics
UTHR
$21.5B
$682K 0.05%
4,753
– –
2 3
4
5 6

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, Perceptive Advisors held 246 positions worth $1.41B, down 9.2% from $1.55B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Perceptive Advisors deployed $78.9M of net new capital in Q4 2016, opening 54 new positions and adding to 32 existing holdings. Its largest new stake was Lakefront Biotherapeutics American Depositary Shares: 304,531 shares worth $20.6M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 97% a quarter earlier, followed by Miscellaneous and Consumer Staples.

On the sell side, the largest reduction was Sarepta Therapeutics, an estimated $25.1M trimmed.

  • Perceptive Advisors's largest Q4 2016 buy was Lakefront Biotherapeutics American Depositary Shares: 304,531 shares worth $20.6M.
  • Perceptive Advisors added most to Neurocrine Biosciences in Q4 2016, an estimated $38M increase.
  • Perceptive Advisors's biggest Q4 2016 reduction was Sarepta Therapeutics, cutting an estimated $25.1M.
  • Perceptive Advisors fully exited DexCom in Q4 2016, selling an estimated $15.7M.
  • Perceptive Advisors's ten largest holdings make up 48% of its $1.41B portfolio in Q4 2016.
  • Perceptive Advisors opened 54 new positions and closed 52 in Q4 2016.
  • Perceptive Advisors's portfolio value fell 9.2% quarter-over-quarter to $1.41B.

Based on Perceptive Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.